Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2013 · 10-Q
Revenue$119.98K$119.98K+767.0% vs Q2 2012 Net Income-$538.82K-$538.82KN/M vs Q2 2012 EPS Diluted-$0.01-$0.01N/M vs Q2 2012 Gross Profit$110,999+1,826.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$362,244N/M Margins · derivedGross margin92.5%+50.9 pt vs Q2 2012
Operating margin-428.5%+10947.7 pt vs Q2 2012
Net margin-449.1%+12386.8 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 14, 2013 · 45 d after period end